chrisvoncsefalvay/vaers-outcomes huggingface dataset:
VAXINATION GIVEN IN LEFT ARM AND LEFT BREAST IS SWOLLEN AND SORE,  DO NOT FEEL INLARGED LYMPH NODES, JUST SORE BREAST AND UNDERARM.
wound up sick with the flu; Initial information received on 10-Oct-2020 regarding an unsolicited valid non-serious case from a consumer/non-health care professional via social media.  This case involves a patient of unknown demographic who wounded up sick for 2 weeks with flu (influenza), after receiving INFLUENZA VACCINE.  Medical history, past medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiration date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient wounded up sick for 2 weeks with flu (influenza) (non-serious) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported as the only time reporter had flu was in basic training  No laboratory data reported.  It was not reported if the patient received a corrective treatment.  At the time of reports, the outcome was not reported for the event influenza.  There will be no information on the batch number for this case.
Physical breakdown, inability to move, slept for 18 of first 24 hrs after injection. headache, upset stomach, mild diahrhea, dehydrated, loss of appetite
100-102 Degree fever, chills, and severe body aches, beginning about 12 hours after first injection and lasting 24 hours. A second 24-hour fever occurred about 3 weeks following my initial dose. This experience was repeated with my second Moderna dose on 4/7/21 with another follow-up fever event about 2 weeks after injection. I have since had even worse reactions to my 2 shot shingles vaccine series, and another fever event on 9/27 in no proximity to a vaccination. The fevers are debilitating enough to prevent me from working and put me in bed for the duration of each event.
fever, chills body aches, shortness of breath, urinary frequency, factigue, headache, body aches, water does not taste good.
Patient was unsure of vaccine dose number. Immtrac2 was checked. However, only dose 1 of 2 was listed. Issue was discovered on return from offsite clinic. Vaccine administered on 8/19/2021 was actually a 3rd dose. Patient had received a second dose of Pfizer vaccine on 8/4/2021.
sick; headaches; chills; pain in the arms; This case was reported by a consumer via (Shingrix   interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 23rd September 2021, the patient received Shingrix. On 23rd September 2021, less than a day after receiving Shingrix, the patient experienced sickness, headache, chills and pain in arm. On an unknown date, the outcome of the sickness, headache, chills and pain in arm were unknown.   It was unknown if the reporter considered the sickness, headache, chills and pain in arm to be related to Shingrix.  Additional details were provided as follows: The patient self reported the case. The age at vaccination was not reported. The patient received shingle shot and felt sick, headaches, chills, pain in the arms. The follow up would not be possible as no contact details were available.
Nausea; Headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 59 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 05Mar2021 12:15 (Lot number: EN6199) at the age of 59 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: NAUSEA (non-serious) with onset 06Mar2021 08:00, outcome "unknown", described as "Nausea"; HEADACHE (non-serious) with onset 06Mar2021 08:00, outcome "unknown", described as "Headache". Therapeutic measures were taken as a result of nausea, headache. Additional information: Patient had no prior vaccinations (within 4 weeks) and no events following prior vaccinations. It was reported that treatment was Tylenol.   No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021355835 same reporter/patient/events, different dose
Information has been received on 22-FEB-2019 regarding a case in litigation from a lawyer concerning a female patient of unknown age. There was no information provided regarding the patient's concurrent conditions, medical history or concomitant medications. The patient was prescribed the ZOSTAVAX by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. In March 2016, the patient was administered the ZOSTAVAX (lot number, expiration, dose and route unknown) by a healthcare provider at a hospital. On an unknown date, the patient was treated by a healthcare provider at a hospital for the following injuries resulting from the patient's ZOSTAVAX use: shingles. The patient claims damages as a result of injury to self, loss of services and economic losses. The outcome of the event was unknown. The causality of the event was considered to be related. Additional information has been requested.
Dizzy, aches, headache, joint pain, ketones( high), vomiting
(R) upper arm - erythema, edema, warm, nodule at injection site. With throbbing on palmar aspect of (R) hand. Tx'd with KEFLEX and Ibuprofen for inflammation.
Hallucinations, fever (TM 102), urticaria (hives).  BENADRYL, ALLEGRA, OVAPRED, MOTRIN given in office.
Pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnancy) in a 34-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included Pregnancy (low birth weight) on 04-Sep-2018. Concurrent medical conditions included Allergy to antibiotic (Amoxicillin, Penicillin.). Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81) for Low birth weight baby, DOXYLAMINE SUCCINATE, PYRIDOXINE HYDROCHLORIDE (DICLEGIS) for Morning sickness, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for Pregnancy.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 18-Jun-2020 and the estimated date of delivery was 01-Apr-2021. On 21-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-first week of the pregnancy.  At the time of the report, EXPOSURE DURING PREGNANCY (Pregnancy) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Sep-2020, Ultrasound scan: unknown (Inconclusive) Unknown. On 19-Nov-2020, Ultrasound scan: unknown (Inconclusive) Unknown. On 23-Dec-2020, Glucose tolerance test: unknown (Inconclusive) Unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 04-Sep-2018, patient had a previous pregnancy that ended with live, full-term birth and had the complication of low birth weight.  The patient reports prior use of alcohol 1-2 drinks/week.  Company Comment: This is a case of product exposure during pregnancy with no associated AEs for this female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
This spontaneous report was received from a patient's mother refers to her 15 year old male son. On an unknown date in August 2012, the patient was vaccinated with GARDASIL (dose 1, route and frequency unspecified) as preventive vaccine. No medical history and concomitant medications were reported. No adverse events were reported for the 1st dose of GARDASIL. On an unknown date in June 2013, the patient received dose 2 of GARDASIL as preventive vaccine and fainted. The patient recovered before leaving the hospital the same day. Causality of the event was not reported. Additional information has been requested.
Pt recv vax on 4/15/99; on 4/25/99 pt exp fever, runny nose, rash on torso, arms, face
Moderna COVID-19 Vaccine EUA Patient presented for booster dose of moderna vaccine on 11/30/21 at approximately 10 am. Booster dose (0.25ml) given in left arm [lot 037F21A exp 2/1/2022]. patient had previously received 1st and 2nd dose moderna vaccines without issue and noted on consent form that only allergy was to pcn antibiotics. booster moderna vaccine given at 10:20 am. pt noticed itching at area of injection and on scalp within minutes but waited until  10:35 am before notifying pharmacist of allergic reaction. in response to reported itching and according to hypersensitivity reaction flowchart, pharmacist administered 50 mg of diphenhydramine IM at  10:37am [lot 6400716 exp 03/2022]. no signs of hives or rash were visible. vitals at 10:43 were WNL BP:124/88 and HR 71. At 10:59 am patient reported throat tightening and difficulty breathing; at 11am 0.3mg epinephrine [lot 0fm518 exp 09/2022] was administered into patient's left thigh. EMS enroute by 11:02am. Vitals at 11:03am: BP 174/166 and HR 87. Pt left AMA with her spouse at 11:10 to get toER. EMS arrived at 11:13am but patient was already at ER.  Patient complained of sore throat and headache at ER. Treated at ER with Solu-Medrol 125mg IV.  Received outpatient prescription for Medrol dose pack and Epipen 0.3mg
Influenza virus vaccine (FLUVRIN) 2008-2009 formula expiration date 6/30/2009 given instead of 2009-2010 formula.  Vaccinated with influenza virus vaccine(FLUZONE) 2009-2010 formula after error discovered.
Immediate swelling, itching and rash down arm and on chest. Changes in menstral cycle staring 4 weeks after and still continuing
Patient came to receive dose 2 of Covid19 Moderna vaccine. States 1 hour after the first dose (administered on  12/28/20) she was at work and her blood pressure dropped, she became dizzy and her face went white. She said her mother insisted she go to the ER to be examined. She states upon examination she was given fluids and tests were ran and the ER staff said she was fine. Explained this to physician at vaccine site and she said it was not a contraindication to receive 2nd dose and it sounds like possible vasovagal reaction or hypoglycemia. Patient states she still wanted to receive vaccine.  Was instructed to monitor patient for 30 minutes after vaccination,  assist patient in ambulation to waiting area to lower fall risk and provided patient with apple juice and trail mix in case of possible hypoglycemia.  About 5-10 minutes after vaccine, patient stated she became dizzy and was dry heaving. She was assisted to supine position; vitals were taken and blood pressure was slightly elevated. 911 was called. Before arrival of EMS, patient stated she was feeling better and vital signs stable. Patient was helped to ambulate around waiting area and upon arrival of EMS, patient states she did not need to be transported. Patient was observed for about 20-25 more minutes and she was fully recovered. Spoke with Dr who was on scene after the incident and she believes it was anxiety.
Fever (101.00 highest), chills, severe body aches, headaches, and a stuffy nose.
I have been breastfeeding a toddler since December 2018 and a baby since September 2020 with no issues. A few days after my 2nd dose I started having very painful clogged milk ducts in my right breast. A few days later it had progressed to mastitis and eventually was in both breasts. I had severe pain, fever, chills, etc. Started taking one antibiotic and after 4 days it still wasn't working so I went to the ER and got switched to a different antibiotic. I don't think the vaccine caused the mastitis but wanted to report it just in case.
developed shingles after receiving the Moderna vaccine; This spontaneous case was reported by a patient and describes the occurrence of HERPES ZOSTER (developed shingles after receiving the Moderna vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     The patient's past medical history included Cancer (resolved until recently) in 2011, Epstein-Barr virus infection (resolved until recently) in 2011 and Shingles (resolved until recently) in 2016.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (developed shingles after receiving the Moderna vaccine). At the time of the report, HERPES ZOSTER (developed shingles after receiving the Moderna vaccine) outcome was unknown. Not provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant Drugs Not Reported. treatment information was provided. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Severe muscle cramp in buttocks & legs, joint pain, nerve (burning) pain in whole body, left arm pain, some right arm pain & weakness. Annual follow-up states the pt has residual effects with unrelenting muscle and nerve pain in legs, feet, ankle, knees, hip. Finger joints constnatly ache.
Patient presented (5 days later) saying that he experienced swelling down the left arm and some pain. Arm is still a little sore but is much better now.
6OCT feel ill, h/a, fever, vomited, sore throat; 10OCT tired easily, cough, rales in lt lung; 13OCT afebrile, palyful, healthy on Amoxil for pneumonia since 10OCT94;
I have had a lump size of a grape in my arm since the injection but almost two weeks after the injection a second small hard lump has formed. Both are tender and really hard.
Redness at the injection site. 101.4 Fever 3/10 /21 11:30 pm- 3/11/21 9:00pm while using Acetaminophen to reduce it. Headache and body aches.
within 2 days was hospitalized & has since had to take a medical leave to deal with her vax injuries; since had to take a medical leave to deal with her vax injuries; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination complication in a female patient who received Men B NVS (Meningococcal B vaccine) for prophylaxis.   On an unknown date, the patient received Meningococcal B vaccine. On an unknown date, 2 days after receiving Meningococcal B vaccine, the patient experienced vaccination complication (Verbatim: within 2 days was hospitalized & has since had to take a medical leave to deal with her vax injuries) (serious criteria hospitalization) and activities of daily living impaired (Verbatim: since had to take a medical leave to deal with her vax injuries). The outcome of the vaccination complication and activities of daily living impaired were not reported.   It was unknown if the reporter considered the vaccination complication and activities of daily living impaired to be related to Meningococcal B vaccine.   It was unknown if the company considered the vaccination complication and activities of daily living impaired to be related to Meningococcal B vaccine.   Additional Information: GSK Receipt Date: 18-JUL-2023 This case was reported by a patient's parent via interactive digital media. The patient received MenB vaccine. The patient needed it to form at her university and within 2 days was hospitalized and had since had to take a medical leave to deal with her vaccine injuries.  The reporter stated that he/she had been always been provac and nor more. The reporter further stated that not to take it.
Chronic spontaneous urticarial rashes after receiving the third dose of the COVID-19 Vaccine (Moderna Vaccine). These rashes appear to be raised erythematous maculopapular wheels. Only Zyretec helps and stops symptoms after 15 minutes, taken daily.
Initial case received from a healthcare professional on 09 July 2014. It is part of a cluster of 2 patients who experienced similar events after administration of ADACEL. The other patient, who was unidentified, is captured in case number 2014SA073710. A 76-year-old female patient received an intramuscular injection of ADACEL (lot number U4875AA) on 02 June 2014 following a dog bite to the right arm and right breast on 01 June 2014. No other medical history was reported. On 04 June 2014, i.e. two days post-vaccination, the patient reported cellulitis. She was seen by her physician on 06 June 2014, and event was resolving. Per the reporter, no testing was done. Additional documents held by sender: None.
I WAS SUPPOSED TO GIVE HER A JANNSEN IMMUNIZATION BUT I MISTAKENLY GAVE HER THE PFIZER ONE INSTEAD. WHEN I DISCOVERED MY ERROR I CONTACTED MY REGIONAL MANAGER WHO TOLD ME TO CONTACT OUR CLINICAL PEOPLE, WHO STATED THE I COULD GIVE HER THE CORRECT IMMUNIZATION WITH NO WAIT TIME. I CONTACTED HER AND INFORMED OF THE MISTAKE, SHE STATED SHE WAS FINE, NO SIDE EFFECTS, AND SHE WOULD COME IN AT HER CONVENIENCE TO GET THE CORRECT ONE.
Pt c/o mild itching about 15 minutes after receiving vaccine, benadryl 25 mg PO given, pt reports relief and no further symptoms after 15 minutes
Got COVID Delta On July 23rd.  Started as a head cold, fever of 100 a couple days, body aches, headache, congestion, cough. DId not lose smell or taste-more fatigued than usual, but continued to have an appetite and was able to do household chores. I just retired but would have found it hard to work especially the first week.  Tylenol helped and naps.
Fever; cough; diarrhea; swelling; burning; This is a spontaneous report from a contactable consumer. A 48-year-old female patient receive first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EK4176) via an unspecified route of administration in right arm on 22Jan2021 12:00 at single dose for COVID-19 immunisation. The patient received the vaccine in hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient medical history was not reported. The patient received unspecified medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced fever, cough, diarrhea, swelling, burning on 22Jan2021 16:00. The patient didn't receive any treatment for events. The outcome of events was recovering.
Information has been received from a registered nurse concerning a 13 year old white female with no drug allergies or pertinent medical history, who on 30-SEP-1996 was vaccinated with the first dose of varicella virus vaccine live (Oka/Merck) (Lot # 617219/0250D) into the left thigh. There was no illness at the time of vaccination. On 03-JUL-2007 in the morning, the patient developed 10 to 12 skin lesions on the face, neck, trunk, and arms. Medical attention was sought via doctor visit. No diagnostic studies or lab tests were performed. The patient was treated with oatmeal (AVEENO) and diphenhydramine HCL (BENADRYL). Subsequently, the patient recovered. There was no product quality complaint. Additional information has been requested.
chills; headache; Energy level low; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 01Mar2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CHILLS (non-serious) with onset 07Mar2021, outcome "unknown", described as "chills"; HEADACHE (non-serious) with onset 07Mar2021, outcome "unknown", described as "headache"; ASTHENIA (non-serious) with onset Mar2021, outcome "unknown", described as "Energy level low".  Additional information: Patient had vaccine March 1st Monday. Energy level was low during the week. Had chills last night when going to bed along with headache.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
discomfort; slight fever; rash on arm; that started to itch; Painful on the site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Painful on the site), PYREXIA (slight fever), VACCINATION SITE RASH (rash on arm), VACCINATION SITE PRURITUS (that started to itch) and DISCOMFORT (discomfort) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included Fish oil and Vitamin D for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE PAIN (Painful on the site). On 06-Feb-2021, the patient experienced PYREXIA (slight fever), VACCINATION SITE RASH (rash on arm) and VACCINATION SITE PRURITUS (that started to itch). On 07-Feb-2021, the patient experienced DISCOMFORT (discomfort). At the time of the report, VACCINATION SITE PAIN (Painful on the site), PYREXIA (slight fever), VACCINATION SITE RASH (rash on arm), VACCINATION SITE PRURITUS (that started to itch) and DISCOMFORT (discomfort) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.